Does VALACYCLOVIR Cause Diffuse large b-cell lymphoma refractory? 43 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 43 reports of Diffuse large b-cell lymphoma refractory have been filed in association with VALACYCLOVIR (Valacyclovir Hydrochloride). This represents 0.3% of all adverse event reports for VALACYCLOVIR.
43
Reports of Diffuse large b-cell lymphoma refractory with VALACYCLOVIR
0.3%
of all VALACYCLOVIR reports
0
Deaths
43
Hospitalizations
How Dangerous Is Diffuse large b-cell lymphoma refractory From VALACYCLOVIR?
Of the 43 reports, 43 (100.0%) required hospitalization.
Is Diffuse large b-cell lymphoma refractory Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VALACYCLOVIR. However, 43 reports have been filed with the FAERS database.
What Other Side Effects Does VALACYCLOVIR Cause?
Acute kidney injury (978)
Drug ineffective (894)
Off label use (593)
Pyrexia (551)
Drug reaction with eosinophilia and systemic symptoms (496)
Confusional state (456)
Rash (423)
Nausea (415)
Neurotoxicity (404)
Altered state of consciousness (395)
What Other Drugs Cause Diffuse large b-cell lymphoma refractory?
RITUXIMAB (461)
CYCLOPHOSPHAMIDE (360)
DOXORUBICIN (345)
VINCRISTINE (331)
ETOPOSIDE (244)
PREDNISONE (214)
EPCORITAMAB-BYSP (198)
CYTARABINE (193)
DEXAMETHASONE (170)
CISPLATIN (156)
Which VALACYCLOVIR Alternatives Have Lower Diffuse large b-cell lymphoma refractory Risk?
VALACYCLOVIR vs VALBENAZINE
VALACYCLOVIR vs VALBENAZINE DITOSYLATE
VALACYCLOVIR vs VALDECOXIB
VALACYCLOVIR vs VALERIAN
VALACYCLOVIR vs VALGANCICLOVIR